ZyVersa Therapeutics' CEO, Stephen C. Glover, to Participate in the 2024 BIO International Convention

ZyVersa is advancing a dynamic pipeline of drug candidates with multiple programs built around two proprietary technologies – Cholesterol Efflux Mediator VAR 200 for treatment of kidney diseases, and Inflammasome

GlobeNewswireMay 14 19:57

Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Shares of Clever Leaves Holdings Inc. (NASDAQ:CLVR) fell sharply during Monday's session after the company announced that it will voluntarily delist its common shares from the Nasdaq and deregister it

BenzingaApr 30 01:04

What's Going On With ZyVersa Stock?

ZyVersa Therapeutics, Inc. (NASDAQ:ZVSA) shares are trading higher Monday after the company announced the publication of a scientific paper in a peer-reviewed journal that reinforces the rationale for

BenzingaApr 29 22:53

ZyVersa Therapeutics Stock Jumps 8%

RTTNewsApr 29 22:19

ZyVersa Therapeutics Shares Resume Trade Following Circuit Breaker Halt

ZyVersa Therapeutics Shares Resume Trade Following Circuit Breaker Halt

BenzingaApr 29 22:07

ImmunityBio, Aquestive Therapeutics, Clever Leaves Holdings Among Healthcare Movers

Seeking AlphaApr 29 22:02